For the first time, ZIMA managed to export the only available biosimilar of KINERET in the world, with the brand name of PerkinRA®️ (manufactured by PersisGen company) to Ukraine and Philippine in 2021.

PerkinRA®️ is prescribed for patients suffering from Rheumatoid Arthritis (RA), Cryopyrin- Associated Periodic Syndrome (CAPS) and Still’s Disease, in which the body produces large amounts of cytokine, called Interleukin-1, which causes harmful effects such as inflammation and development of disease symptoms.

PerkinRA®️ has been manufactured by DNA technology using E.coli microorganism and it is used in combination with methotrexate to treat RA symptoms in adults (age 18 years and older).

According to an exclusive agreement between PersisGen and ZIMA, we are proud to announce that ZIMA is the sole exclusive agent of PersisGen in all exporting markets.
PersisGen’s products are exported to more than 3 countries and they are in registration procedure in more than 7 markets.